By Conor Hale
The company said its devices have been able to detect nearly half of COVID-19 cases at least one day before the participant reported any fever, cough or pain.
read more
By Paige Minemyer
COVID-19 shows no signs of letting up soon. So medical schools are adapting their plans for education in the fall to meet the demands of the pandemic.
read more
By Kyle Blankenship
Despite hundreds of potential COVID-19 therapies looking to make their case, very few have crossed the finish line. One promising candidate, Regeneron's two-antibody cocktail, has earned early plaudits—and now a pharma giant is jumping aboard to help boost manufacturing.
read more
By Eric Sagonowsky, Angus Liu, Kyle Blankenship, Conor Hale, Fraiser Kansteiner
FitBit unveiled early data on its activity trackers' ability to detect COVID-19 before symptoms manifest. Qiagen rolled out new tools to help researchers track viral mutations. The Center for Health Security at Johns Hopkins unveiled an ethical vaccine distribution scheme. Plus, hospitals spent less on COVID patients in July, but costs may rise again with remdesivir purchases.
read more
By Healthcare Staff
Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.
read more
By Robert King
Banner Health generated $4.7 billion in the first half of 2020 as the hospital system fights to blunt declining patient volumes due to COVID-19.
read more
By Fraiser Kansteiner
With an AstraZeneca vaccine deal confirmed and negotiations ongoing with other shot-makers, the Australian government is looking to domestic manufacturer CSL to churn out supplies. CSL has already partnered with the University of Queensland on its own vaccine hopeful and snared a deal with CEPI to further that work.
read more
By Ben Adams
China-based life science giant WuXi AppTec has seen its contract research unit tick up, but it's still being hit by pandemic challenges.
read more
By Paige Minemyer
Employer on-site clinics have proved nimble in the face of COVID-19—so expect their appeal to continue to grow, a new survey shows.
read more
By Conor Hale
Qiagen launched new tools to capture and track emerging mutations in the novel coronavirus, which can lead to new strains that may change how the world responds to the COVID-19 pandemic.
read more
